Furthermore, using a human 3D organotypic skin model of AD, we demonstrate the benefit of the pharmacological inhibition of NAMPT and PARP1, which reduce AD-associated inflammation and keratinocyte proliferation. The gene discussed is PARP1; the disease is Alzheimer disease.